However, it has been reported that the overexpression of Bcl-2 and Mcl-1 in various hematologic cancers, including NHL, may lead to dysregulation of the apoptosis rate, benefiting cancer progression [18,19,20]. This evidence concerns the gene BCL2 and hematopoietic and lymphoid cell neoplasm.